HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Google Scholar Articles by Ogilvie, C. M. PubMed Articles by Ogilvie, C. M.

Preimplantation testing for chromosome aneuploidy

^1. Guy’s and St Thomas’ Centre for Preimplantation Genetic Diagnosis and Cytogenetics Department, 5th floor, Tower Wing, Guy’s and St Thomas’ NHS Foundation Trust, St Thomas’ Street, London SE1 9RT, UK Email: caroline.ogilvie{at}genetics.kcl.ac.uk (corresponding author)

Key content:

• Around 50% of cleavage stage human embryos obtained by in vitro fertilisation (IVF) have an abnormal number of chromosomes.
  
• Aneuploidy testing has been introduced at some IVF centres with the aim of identifying and removing abnormal embryos and increasing pregnancy success rates.
  
• Randomised controlled trials have indicated that pregnancy and live birth rates are lower for women undergoing aneuploidy testing.
  

Learning objectives:

• To understand the nature and frequency of chromosome abnormalities in cleavage stage human embryos.
  
• To understand the rationale underlying aneuploidy testing.
  
• To understand the results of research on aneuploidy testing.
  

Ethical issues:

• Should aneuploidy testing be offered, when randomised trials indicate either that it has no effect or that it results in fewer ongoing pregnancies and live births?
  

Please cite this article as: Ogilvie CM. Preimplantation testing for chromosome aneuploidy. The Obstetrician & Gynaecologist 2008;10:88–92.

Keywords aneuploidy testing / comparative genomic hybridisation / fluorescence in situ hybridisation / in vitro fertilisation / preimplantation genetic diagnosis